Pulmonx Corporation (NASDAQ:LUNG) is considered one of the best stocks under $3 to invest in. Lake Street lowered the price target on Pulmonx to $4 from $8 but maintained a Buy rating. Stifel Nicolaus analyst Rick Wise set a price target of $5.00, while Canaccord Genuity’s John Young CFA set a target of $6.00. Pulmonx provides a minimally invasive treatment for patients with severe emphysema. Despite its potential, some believe other AI stocks offer greater upside potential. For those interested in AI stocks, check out the best short-term AI stock.

Read more at Yahoo Finance: Is Pulmonx Corporation (LUNG) One of the Best Stocks Under $3 to Invest In?